Podcast Episode 7: Dispelling Myths about CGM Coverage

Guest Speaker: Manisha Agarwal, Sr Director, Patient Support Services, Dexcom

Real-time real talk is intended for healthcare professionals in the US.

Listen in to learn about common myths and misconceptions about Dexcom CGM coverage.  Guest speaker, Manisha Agarwal, is a Dexcom employee and is a guest on this episode of the podcast. Dexcom G6 is covered for 3 out of 4 patients with T2D on mealtime insulin with commercial health insurance plans.*  Dexcom has three times more patients paying $0 than competing CGM systems 2  and is currently reimbursed by more than 97% of private insurance 1  as well as Medicare nationwide and Medicaid in 45 states. CMS has proposed expanding Medicare coverage for CGMs to include people who are treated with insulin at least once per day or who have a history of problematic hypoglycemia. For Dexcom's Coverage Evaluator, click here.